The drugmaker Zogenix says a harder-to-abuse version of its powerful painkiller Zohydro could be reviewed by regulators this fall and, if approved, might hit the market early next year.
Zohydro maker details timeframe for harder-to-abuse version
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.